Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-02-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$224.7m reported value -5.5% vs Q3 2022
12positions
93.8%in top 10
0 new 6 added 5 reduced 2 sold out vs Q3 2022

Options: 0 call positions (— notional), 1 put positions ($41.5m notional) – listed below, not included above.

Holdings, Q4 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,103,515 $44.8m19.92% 19.92% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.1m -115.0k -115,000 -9.4%
2 BLUEPRINT MEDICINES CORP COM BPMC BPMC 581,768 $25.5m11.34% 11.34% AddedShares held: Q3 2022 524.3k, Q4 2022 581.8k +57.5k +57,500 11.0%
3 ARVINAS INC COM ARVN ARVN 673,941 $23.1m10.26% 10.26% AddedShares held: Q3 2022 671.7k, Q4 2022 673.9k +2.2k +2,196 0.3%
4 MERUS N V COM MRUS MRUS 1,432,109 $22.2m9.86% 9.86% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m -75.0k -75,000 -5.0%
5 REGENXBIO INC COM RGNX RGNX 897,684 $20.4m9.06% 9.06% ReducedShares held: Q3 2022 967.7k, Q4 2022 897.7k -70.0k -70,000 -7.2%
6 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,284,133 $19.6m8.71% 8.71% AddedShares held: Q3 2022 1.3m, Q4 2022 1.3m +21.0k +21,008 1.7%
7 KYMERA THERAPEUTICS INC COM KYMR KYMR 629,411 $15.7m6.99% 6.99% AddedShares held: Q3 2022 330.2k, Q4 2022 629.4k +299.2k +299,165 90.6%
8 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 2,098,993 $15.3m6.82% 6.82% AddedShares held: Q3 2022 2.0m, Q4 2022 2.1m +100.0k +100,000 5.0%
9 UNIQURE NV SHS QURE QURE 624,854 $14.2m6.30% 6.30% ReducedShares held: Q3 2022 841.5k, Q4 2022 624.9k -216.6k -216,617 -25.7%
10 GENMAB A/S SPONSORED ADS GMAB GMAB 242,848 $10.3m4.58% 4.58% ReducedShares held: Q3 2022 244.8k, Q4 2022 242.8k -2.0k -2,000 -0.8%
11 ARGENX SE SPONSORED ADR ARGX ARGX 24,000 $9.1m4.05% 4.05% UnchangedShares held: Q3 2022 24.0k, Q4 2022 24.0k
12 PIERIS PHARMACEUTICALS INC COM COM 4,552,876 $4.7m2.11% 2.11% AddedShares held: Q3 2022 4.0m, Q4 2022 4.6m +516.6k +516,596 12.8%

Sold out since Q3 2022

SecurityTickerShares held beforeValue then
SPERO THERAPEUTICS INC SPRO SPRO 3,403,210 $6.8m3.4m shares
4D MOLECULAR THERAPEUTICS IN FDMT FDMT 3,573 $29.0k3.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 500,000 $41.5m500.0k shares Unchanged